Concepedia

Nadine Bizouarne

NB

13

Publications

1.1K

Citations

12

H-Index

1996

Active since

Affiliations

Transgene (France)(Current)

Inserm

Hôpital Européen Georges-Pompidou

Hôpital Européen

Greater Poland Cancer Center

Nadine Bizouarne is an author at Transgene (France) specializing in medicine, immunology, and immunotherapy.

Top concepts

Publications per year

1996–2011

13

Publications

13

Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial

Élisabeth Quoix, Rodryg Ramlau, Virginie Westeel et al. · The Lancet Oncology · 2011 · 264 citations

, , +10

A Phase II Study of Tg4010 (Mva-Muc1-Il2) in Association with Chemotherapy in Patients with Stage III/IV Non-small Cell Lung Cancer

Rodryg Ramlau, Élisabeth Quoix, Janusz Rolski et al. · Journal of Thoracic Oncology · 2008 · 202 citations

, , +7

Phase I immunotherapy with a modified vaccinia virus (MVA) expressing human MUC1 as antigen‐specific immunotherapy in patients with MUC1‐positive advanced cancer

Christoph Rochlitz, Robert A. Figlin, Patrick Squiban et al. · The Journal of Gene Medicine · 2003 · 172 citations

Recombinant Vaccinia Virus Encoding Human MUC1 and IL2 as Immunotherapy in Patients With Breast Cancer

Jean-Marc Balloul, Gwenaelle Le Goc, Nadine Bizouarne et al. · Journal of Immunotherapy · 2000 · 130 citations

MUC1-specific immune responses in human MUC1 transgenic mice immunized with various human MUC1 vaccines

Bruce Acres, Vasso Apostolopoulos, Jean‐Marc Balloul et al. · Cancer Immunology Immunotherapy · 2000 · 95 citations · Full text

, , +9

Rows per page

1–5 of 13